| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |